INVISTA makes advancements and remains confident in China ADN project
INVISTA continues to make progress on its planned 400,000-ton adiponitrile (ADN) plant at the Shanghai Chemical Industry Park (SCIP). This $1.2 billion USD (8.4 billion RMB) investment will help meet the growing demand for nylon 6,6 chemical intermediates in China and the Asia Pacific region.
In January, the project obtained Environmental Impact Assessment (EIA) approval and Safety Condition Review approval. Detailed engineering and procurement on the project are well underway—with awards already made for more than 90 percent of process equipment. INVISTA plans to begin construction on the project this year and start production in 2022.
"We are confident about China’s demand growth and continue to advance our investment at SCIP," said Kyle Redinger, vice president INVISTA Intermediates Asia Pacific. “By our estimates, China could be the world’s largest consumer of nylon 6,6 in the next few years, and we believe it’s important to serve China from China to realize the full growth potential. We will continue our efforts to satisfy the strong local and regional demand for high-quality nylon products.”
When complete, INVISTA’s new ADN plant will integrate with its existing HMD and polymer facilities to directly supply domestic customers with the key building blocks to produce nylon 6,6 and other high-value products in China and throughout the Asia Pacific region. These products are used for the automobile industry, electrical & electronic industry and many other consumer and industrial applications—contributing to the overall quality of life by enabling lightweight, heat-resistant and durable designs.
INVISTA’s latest ADN technology brings improved product yields, reduced energy consumption, lower greenhouse gas emissions, enhanced process stability and reduced capital intensity compared to existing technologies.
INVISTA will continue to work closely with all stakeholders as we advance our commitment to this project and China.